The UK needs patient capital but Neil Woodford is not the man to deliver it
Other fund managers are starting to reap the rewards of this much-needed area of domestic investment
Other fund managers are starting to reap the rewards of this much-needed area of domestic investment
|
|
Simon Clarke MP says study will help DC pension savers achieve financial stability in retirement
|
|
Equities manager boasted of government support for patient capital as trust struggled
|
|
Budget 2018 sought to reduce barriers to investing in illiquid UK growth businesses
|
|
Andrew Bailey says stakes are getting higher for securing the confidence of the public
|
|
DC schemes could be forced to allocate to UK start-ups
|
|
The initial public offering (IPO) of biotech company Autolus is a “step in the right direction” for Neil Woodford’s Patient Capital trust but investors should be prepared for a bumpy ride, according to Winterflood Securities.
|
|
The government has sought feedback on four EIS fund models to direct capital into knowledge-intensive companies, arguing the structure is best placed to stimulate investment into the early-stage companies.
|
|
Patient Capital Review changes implemented by the government mean Albion Capital has confirmed its VCT offers are fully subscribed at its new reduced target of £32m, shy of the £38m it initially hoped to raise.
|
|
Baillie Gifford has announced its intention to raise £250m by launching a patient capital trust that will target American companies with long-term growth prospects.
|
|
Investor interest in tax-efficient EIS funds is expected to rise despite managers being forced into higher-risk investments as a result of recent rule changes.
|
|
Symvan Capital is targeting wealth managers with the launch of its third Seed Enterprise Investment Scheme fund for tax-efficient investing in UK startups.
|
|